ArticleFrontiers in pediatrics2026
Age
Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This study aimed to evaluate whether Methods: We conducted a retrospective cohort study of children with Results: A total of 150 children were enrolled, with 13 in the macrolide resistance gene-negative group and 137 in the positive group, resulting in a macrolide resistance gene positivity rate of 91.3%. Of these patients Conclusion: In the Nanchong area, macrolide resistance mediated by the 23S rRNA A2063G mutation predominates. Resistance gene detection alone indicates only potential resistance but cannot independently guide antibiotic switching. Among gene-positive children, elevated CRP and older age are early predictors of switching need, while prolonged hospital stay serves as a retrospective confirmatory marker. Clinical decisions should integrate these biomarkers rather than relying solely on genetic results.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.